Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Change in Account Payables came in at $390000.0 in Q1 2026, down 4.88% YoY from $410000.0 in Q1 2025, and up 129.79% on a QoQ basis from -$1.3 million in Q4 2025.
Cytek Biosciences (CTKB) Change in Account Payables (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Change in Account Payables data on file, last reported at $390000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 4.88% year-over-year to $390000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428000.0 (down 81.99% YoY) and the FY2025 annual result came in at $448000.0, down 82.65% from the prior year.
- Change in Account Payables grew to $390000.0 in Q1 2026, from -$1.3 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.8 million in Q1 2022 to a low of -$2.0 million in Q2 2023.
- A 5-year average of $205764.7 and a median of $390000.0 in 2026 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 2383.93% — and 2025, when it plunged 607.36%.
- Tracing CTKB's Change in Account Payables over 5 years: stood at -$908000.0 in 2022, then slumped by 97.58% to -$1.8 million in 2023, then soared by 114.38% to $258000.0 in 2024, then sank by 607.36% to -$1.3 million in 2025, then surged by 129.79% to $390000.0 in 2026.
- The last three Change in Account Payables figures came in at $390000.0 (Q1 2026), -$1.3 million (Q4 2025), and $588000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Cytek Biosciences | 610.41 Mn | 536.56 Mn | 28.34 Mn | 1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.74 Mn |
| Jun 30, 2026 | 1.74 Mn |
| Mar 31, 2026 | 390,000.00 |
| Mar 31, 2026 | 390,000.00 |
| Dec 31, 2025 | -1.31 Mn |
| Dec 31, 2025 | -1.31 Mn |
| Sep 30, 2025 | 588,000.00 |
| Sep 30, 2025 | 588,000.00 |
| Jun 30, 2025 | 759,000.00 |
| Jun 30, 2025 | 759,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 2.23 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | -519,000.00 |
| Jun 30, 2024 | -519,000.00 |
| Mar 31, 2024 | 615,000.00 |
| Mar 31, 2024 | 615,000.00 |